Annual Report — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for Digene Corp 83 401K
2: EX-10.37 Stock Purchase Agreement Dated as of June 30,1998 37 128K
3: EX-21 Subsidiaries of the Registrant 1 4K
4: EX-23.1 Consent of Ernst & Young LLP 1 6K
5: EX-27 Financial Data Schedule 1 6K
EX-23.1 — Consent of Ernst & Young LLP
EX-23.1 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
---|
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements
(Form S-8 No. 333-14933 and Form S-8 No. 333-40899) pertaining to the Digene
Diagnostics, Inc. 1990 Stock Option Plan, the Digene Diagnostics, Inc. 1991- A
Stock Option Plan, the Digene Diagnostics, Inc. 1991-B Stock Option Plan, the
Digene Corporation Omnibus Plan, the Digene Corporation Directors' Stock Option
Plan, and the Digene Corporation 1997 Stock Option Plan of our reports dated
August 17, 1998, with respect to the consolidated financial statements and
schedule of Digene Corporation included in its Annual Report on Form 10-K for
the year ended June 30, 1998, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Vienna, Virginia
September 25, 1998
Dates Referenced Herein
This ‘10-K’ Filing | | Date | | Other Filings |
---|
| | |
Filed on: | | 9/28/98 | | None on these Dates |
| | 9/25/98 |
| | 8/17/98 |
For Period End: | | 6/30/98 |
| List all Filings |
↑Top
Filing Submission 0000950133-98-003401 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., Apr. 19, 10:09:54.1pm ET